Literature DB >> 3840629

Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status.

S E Rivkin, W A Knight, R McDivitt, T Cruz, M Foulkes, C K Osborne, C J Fabian, J J Costanzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3840629     DOI： 10.1007/bf01655187

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  8 in total

1.  Current status of estrogen receptors in human breast cancer.

Authors:  W L McGuire
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

3.  Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.

Authors:  H Glucksberg; S E Rivkin; S Rasmussen; B Tranum; N Gad-el-Mawla; J Costanzi; B Hoogstraten; J Athens; T Maloney; J McCracken; C Vaughn
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

4.  Antiestrogen-induced remissions in stage IV breast cancer.

Authors:  A Manni; J Trujillo; J S Marshall; O H Pearson
Journal:  Cancer Treat Rep       Date:  1976-10

5.  Evaluation of tamoxifen dose in advanced breast cancer: a progress report.

Authors:  D C Tormey; R M Simon; M E Lippman; J M Bull; C E Myers
Journal:  Cancer Treat Rep       Date:  1976-10

Review 6.  Current status of estrogen and progesterone receptors in breast cancer.

Authors:  W L McGuire; K B Horwitz; O H Pearson; A Segaloff
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

7.  Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer.

Authors:  H J Lerner; P R Band; L Israel; B S Leung
Journal:  Cancer Treat Rep       Date:  1976-10

8.  Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.

Authors:  L R Morgan; P S Schein; P V Woolley; D Hoth; J Macdonald; M Lippman; L E Posey; R W Beazley
Journal:  Cancer Treat Rep       Date:  1976-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.